{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:55:50Z","timestamp":1765040150969},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1007\/s11926-996-0045-z","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T13:52:17Z","timestamp":1180792337000},"page":"235-241","source":"Crossref","is-referenced-by-count":14,"title":["Recent advances in the epidemiology of gout"],"prefix":"10.1007","volume":"7","author":[{"given":"Kenneth G.","family":"Saag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted R.","family":"Mikuls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"45_CR1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/ard.38.2.101","volume":"38","author":"W Currie","year":"1979","unstructured":"Currie W: Prevalence and incidence of the diagnosis of gout in Great Britain. Ann Rheum Dis 1979, 38:101\u2013106.","journal-title":"Ann Rheum Dis"},{"key":"45_CR2","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/0895-4356(94)00244-K","volume":"48","author":"C Harris","year":"1995","unstructured":"Harris C, Lloyd C, Lewis J: The prevalence and prophylaxis of gout in England. J Clin Epidemiol 1995, 48:1153\u20131158.","journal-title":"J Clin Epidemiol"},{"key":"45_CR3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2004.024091","volume":"64","author":"T Mikuls","year":"2005","unstructured":"Mikuls T, Farrar J, Bilker W, et al.: Gout epidemiology: results from the U.K. General Practice Research Database, 1990\u20131999. Ann Rheum Dis 2005, 64:267\u2013272. Recently updated incidence and prevalence estimates based on data analysis from the electronic medical record of a sizable population of patients followed-up by generalists in the United Kingdom.","journal-title":"Ann Rheum Dis"},{"key":"45_CR4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/ard.56.1.22","volume":"56","author":"P Klemp","year":"1997","unstructured":"Klemp P, Stansfield S, Castle B, Robertson M: Gout is on the increase in New Zealand. Ann Rheum Dis 1997, 56:22\u201326.","journal-title":"Ann Rheum Dis"},{"key":"45_CR5","first-page":"295","volume":"65","author":"I Prior","year":"1966","unstructured":"Prior I, Rose B: Uric acid, gout and public health in the South Pacific. NZ Med J 1966, 65:295\u2013300.","journal-title":"NZ Med J"},{"key":"45_CR6","first-page":"1","volume":"189","author":"V Benson","year":"1992","unstructured":"Benson V, Marano M: Current estimates from the National Health Interview Survey, 1992. Vital Health Stat 1992, 189:1\u2013269.","journal-title":"Vital Health Stat"},{"key":"45_CR7","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","volume":"41","author":"R Lawrence","year":"1998","unstructured":"Lawrence R, Helmick C, Arnett F, et al.: Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998, 41:778\u2013799.","journal-title":"Arthritis Rheum"},{"key":"45_CR8","first-page":"427","volume":"16","author":"R Lawrence","year":"1989","unstructured":"Lawrence R, Hochberg M, Kelsey J, et al.: Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 1989, 16:427\u2013441.","journal-title":"J Rheumatol"},{"key":"45_CR9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0895-4356(88)90127-8","volume":"41","author":"RD Abbott","year":"1988","unstructured":"Abbott RD, Brand FN, Kannel WB, Castelli WP: Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol 1988, 41:237\u2013242.","journal-title":"J Clin Epidemiol"},{"key":"45_CR10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0002-9343(67)90004-6","volume":"42","author":"A Hall","year":"1967","unstructured":"Hall A, Barry P, Dawber T, McNamara P: Epidemiology of gout and hyperuricemia: a long-term population study. Am J Med 1967, 42:27\u201337.","journal-title":"Am J Med"},{"key":"45_CR11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/ard.31.3.166","volume":"31","author":"J O\u2019Sullivan","year":"1972","unstructured":"O\u2019Sullivan J: Gout in a New England town: a prevalence study in Sudbury, Massachusetts. Ann Rheum Dis 1972, 31:166\u2013169.","journal-title":"Ann Rheum Dis"},{"key":"45_CR12","first-page":"2403","volume":"29","author":"E Aromdee","year":"2002","unstructured":"Aromdee E, Michet C, Crowson C, et al.: Epidemiology of gout: is the incidence rising? J Rheumatol 2002, 29:2403\u20132406. An excellent epidemiologic study using the Rochester Epidemiology Cohort demonstrating variable rates of gout over time.","journal-title":"J Rheumatol"},{"key":"45_CR13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2004.024091","volume":"64","author":"T Mikuls","year":"2005","unstructured":"Mikuls T, Farrar J, Bilker W, et al.: Gout epidemiology: results from the U.K. General Practice Research Database, 1990\u20131999. Ann Rheum Dis 2005, 64:267\u2013272.","journal-title":"Ann Rheum Dis"},{"key":"45_CR14","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1001\/jama.1991.03470210072035","volume":"266","author":"R Roubenoff","year":"1991","unstructured":"Roubenoff R, Klag M, Mead L, et al.: Incidence and risk factors for gout in white men. JAMA 1991, 266:3004\u20133007.","journal-title":"JAMA"},{"key":"45_CR15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","volume":"82","author":"E Campion","year":"1987","unstructured":"Campion E, Glynn R, DeLabry L: Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987, 82:421\u2013426.","journal-title":"Am J Med"},{"key":"45_CR16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/rheumatology\/29.6.485","volume":"29","author":"O Stewart","year":"1990","unstructured":"Stewart O, Silman A: Review of UK data on the rheumatic diseases-4 Gout. Br J Rheumatol 1990, 29:485\u2013488.","journal-title":"Br J Rheumatol"},{"key":"45_CR17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00002512-199813030-00006","volume":"13","author":"A Fam","year":"1998","unstructured":"Fam A: Gout in the elderly: clinical presentation and treatment. Drugs Aging 1998, 13:229\u2013243.","journal-title":"Drugs Aging"},{"key":"45_CR18","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/art.20438","volume":"50","author":"J Bieber","year":"2004","unstructured":"Bieber J, Terkeltaub R: On the brink of novel therapeutic options for an ancient disease. Arthritis Rheum 2004, 50:2400\u20132414.","journal-title":"Arthritis Rheum"},{"key":"45_CR19","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","volume":"283","author":"J Fang","year":"2000","unstructured":"Fang J, Alderman M: Serum uric acid and cardiovascular mortality: NHANES I epidemiologic follow-up study, 1971\u20131992. JAMA 2000, 283:2404\u20132410. A secondary analysis of a large, highly generalizable, national survey that showed an increased risk for cardiovascular mortality among person with higher uric acid levels.","journal-title":"JAMA"},{"key":"45_CR20","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/art.1780380508","volume":"38","author":"M Hochberg","year":"1995","unstructured":"Hochberg M, Thomas J, Thomas D, et al.: Racial differences in the incidence of gout: the role of hypertension. Arthritis Rheum 1995, 38:628\u2013632.","journal-title":"Arthritis Rheum"},{"key":"45_CR21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/0091-7435(90)90045-L","volume":"19","author":"G Burke","year":"1990","unstructured":"Burke G, Jacobs D, Sprafka J, et al.: Obesity and overweight in young adults: the CARDIA study. Prev Med 1990, 19:476\u2013488.","journal-title":"Prev Med"},{"key":"45_CR22","unstructured":"US Renal Data System. USRDS 1999 annual data report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1999."},{"key":"45_CR23","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa035700","volume":"350","author":"H Choi","year":"2004","unstructured":"Choi H, Atkinson K, Karlson E, et al.: Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004, 350:1093\u20131103. An investigation using the Health Professionals Follow-up Study showing provocative associations of animal but not vegetable food sources of purines with gout","journal-title":"N Engl J Med"},{"key":"45_CR24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ajcn\/53.3.665","volume":"53","author":"D Garrel","year":"1991","unstructured":"Garrel D, Verdy M, PetitClerc C, et al.: Milk- and soy-protein ingestion: acute effect on serum uric acid concentration. Am J Clin Nutr 1991, 53:665\u2013669.","journal-title":"Am J Clin Nutr"},{"key":"45_CR25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF01719431","volume":"11","author":"P Ghadirian","year":"1995","unstructured":"Ghadirian P, Shatenstein B, Verdy M, Hamet P: The influence of dairy products on plasma uric acid in women. Eur J Epidemiol 1995, 11:275\u2013281.","journal-title":"Eur J Epidemiol"},{"key":"45_CR26","first-page":"309","volume":"8","author":"L Blau","year":"1950","unstructured":"Blau L: Cherry diet control for gout and arthritis. Tex Rep Biol Med 1950, 8:309\u2013311.","journal-title":"Tex Rep Biol Med"},{"key":"45_CR27","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/jn\/133.6.1826","volume":"133","author":"R Jacob","year":"2003","unstructured":"Jacob R, Spinozzi G, Simon V, et al.: Consumption of cherries lowers plasma urate in healthy women. J Nutr 2003, 133:1826\u20131829.","journal-title":"J Nutr"},{"key":"45_CR28","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(04)16000-5","volume":"363","author":"H Choi","year":"2004","unstructured":"Choi H, Atkinson K, Karlson E, et al.: Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004, 363:1277\u20131281. Another paper using the Health Professionals Follow-up Study demonstrating higher risk for gout with increased exposure to beer and spirits but not with wine","journal-title":"Lancet"},{"key":"45_CR29","first-page":"1708","volume":"27","author":"N Shadick","year":"2000","unstructured":"Shadick N, Kim R, Weiss S, et al.: Effect of low level lead exposure on hyperuricemia and gout among middle aged and elderly men: the normative aging study. J Rheumatol 2000, 27:1708\u20131712. The development of gout due to high levels of lead exposure (saturine gout) is an association of long reported interest. This paper highlights a newer interest in gout risk after lower level lead exposure.","journal-title":"J Rheumatol"},{"key":"45_CR30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/rheumatology\/23.3.203","volume":"23","author":"T Gibson","year":"1984","unstructured":"Gibson T, Rodgers A, Simmonds H, Toseland P: Beer drinking and its effect on uric acid. Br J Rheumatol 1984, 23:203\u2013209.","journal-title":"Br J Rheumatol"},{"key":"45_CR31","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/art.20821","volume":"51","author":"HK Choi","year":"2004","unstructured":"Choi HK, Curhan G: Beer, liquor, and wine consumption and serum uric acid level: The third National Health and Nutrition Examination Survey. Arthritis Rheum 2004, 51:1023\u20131029. In this large U.S. population-based survey, a significant and positive relationship was confirmed between high alcoholic beverage consumption and greater levels of uric acid.","journal-title":"Arthritis Rheum"},{"key":"45_CR32","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0002-9343(02)01296-2","volume":"113","author":"J-L Lin","year":"2002","unstructured":"Lin J-L, Tan D-T, Ho H-H, Yu C-C: Environmental lead exposure and urate excretion in the general population. Am J Med 2002, 113:563\u2013568. Body lead burden increased a persons gout risk based on this cross-sectional Taiwanese data.","journal-title":"Am J Med"},{"key":"45_CR33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archinte.1987.00370040027005","volume":"147","author":"HG Langford","year":"1987","unstructured":"Langford HG, Blaufox MD, Borhani NO, et al.: Is thiazideproduced uric acid elevation harmful: analysis of data from the Hypertension Detection and Follow-up Program. Arch Intern Med 1987, 147:645\u2013649.","journal-title":"Arch Intern Med"},{"key":"45_CR34","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","unstructured":"The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Anti-hypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288:2981\u20132987.","journal-title":"JAMA"},{"key":"45_CR35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0002-9343(92)90104-J","volume":"92","author":"DA Burack","year":"1992","unstructured":"Burack DA, Griffith BP, Thompson ME, Kahl LE: Hyperuricemia and gout among heart transplant recipients receiving cyclosporine. Am J Med 1992, 92:141\u2013146.","journal-title":"Am J Med"},{"key":"45_CR36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0140-6736(85)91902-6","volume":"325","author":"JR Chapman","year":"1985","unstructured":"Chapman JR, Harding NGL, Griffiths D, Morris PJ: Reversibility of cyclosporin nephrotoxicity after three months\u2019 treatment. Lancet 1985, 325:128\u2013130.","journal-title":"Lancet"},{"key":"45_CR37","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1681\/ASN.V115974","volume":"11","author":"DM Clive","year":"2000","unstructured":"Clive DM: Renal transplant-associated hyperurecemia and gout. J Am Soc Nephrol 2000, 11:974\u2013979.","journal-title":"J Am Soc Nephrol"},{"key":"45_CR38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJM198908033210504","volume":"321","author":"HY Lin","year":"1989","unstructured":"Lin HY, Rocher LL, McQuillan MA, et al.: Cyclosporineinduced hyperuricemia and gout. N Engl J Med 1989, 321:287\u2013292.","journal-title":"N Engl J Med"},{"key":"45_CR39","first-page":"1391","volume":"24","author":"KJ Ahn","year":"1992","unstructured":"Ahn KJ, Kim YS, Lee HC, et al.: Cyclosporine-induced hyperuricemia after renal transplant: clinical characteristics and mechanisms. Transplant Proc 1992, 24:1391\u20131392.","journal-title":"Transplant Proc"},{"key":"45_CR40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/1529-0131(200001)43:1<103::AID-ANR13>3.0.CO;2-C","volume":"43","author":"D Caspi","year":"2000","unstructured":"Caspi D, Lubart E, Graff E, et al.: The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum 2000, 43:103\u2013108.","journal-title":"Arthritis Rheum"},{"key":"45_CR41","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.7326\/0003-4819-34-6-1421","volume":"34","author":"MM Gertler","year":"1951","unstructured":"Gertler MM, Gam SM, Levine SA: Serum uric acid in relation to age and physique in health and coronrary heart disease. Ann Intern Med 1951, 34:1421\u20131431.","journal-title":"Ann Intern Med"},{"key":"45_CR42","first-page":"319","volume":"14","author":"JT Scott","year":"1976","unstructured":"Scott JT, Sturge RA: The effect of weight loss on plasma and urinary uric acid and lipid levels. J Clin Chem Clin Biochem 1976, 14:319.","journal-title":"J Clin Chem Clin Biochem"},{"key":"45_CR43","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/ajcn\/78.6.1068","volume":"78","author":"MP St-Onge","year":"2003","unstructured":"St-Onge MP, Keller KL, Heymsfield SB: Changes in childhood food consumption patterns: a cause for concern in light of increasing body weights. Am J Clin Nutr 2003, 78:1068\u20131073.","journal-title":"Am J Clin Nutr"},{"key":"45_CR44","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1536\/jhj.44.527","volume":"44","author":"A Bedir","year":"2003","unstructured":"Bedir A, Topbas M, Tanyeri F, et al.: Leptin might be a regulator of serum uric acid concentrations in humans. Jpn Heart J 2003, 44:527\u2013536. This study provides a provocative glimpse into a potential biological mechanism that could help explain the association between obesity and gout.","journal-title":"Jpn Heart J"},{"key":"45_CR45","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1515\/JPEM.2003.16.9.1225","volume":"16","author":"C Denzer","year":"2003","unstructured":"Denzer C, Muche R, Mayer H, et al.: Serum uric acid levels in obese children and adolescents: linkage to testosterone levels and pre-metabolic syndrome. J Pediatr Endocrinol Metab 2003, 16:1225\u20131232.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"45_CR46","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/ije\/28.5.888","volume":"28","author":"N Nakanishi","year":"1988","unstructured":"Nakanishi N, Tatara K, Nakamura K, Suzuki K: Risk factors for the incidence of hyperuricaemia: a 6-year longitudinal study of middle-aged Japanese men. Int J Epidemiol 1988, 28:888\u2013893.","journal-title":"Int J Epidemiol"},{"key":"45_CR47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0140-6736(66)90005-5","volume":"1","author":"Breckenridge A","year":"1966","unstructured":"Breckenridge A: Hypertension and hyperuricaemia. Lancet 1966, 1:15\u201318.","journal-title":"Lancet"},{"key":"45_CR48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00129784-200303050-00001","volume":"3","author":"AR Gavin","year":"2003","unstructured":"Gavin AR, Struthers AD: Hyperuricemia and adverse outcomes in cardiovascular disease: potential for therapeutic intervention. Am J Cardiovasc Drugs 2003, 3:309\u2013314.","journal-title":"Am J Cardiovasc Drugs"},{"key":"45_CR49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.HYP.0000085858.66548.59","volume":"42","author":"DI Feig","year":"2003","unstructured":"Feig DI, Johnson RJ: Hyperuricemia in childhood primary hypertension. Hypertension 2003, 42:247\u2013252.","journal-title":"Hypertension"},{"key":"45_CR50","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000186593","volume":"59","author":"A Tykarski","year":"1991","unstructured":"Tykarski A: Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion. Nephron 1991, 59:364\u2013368.","journal-title":"Nephron"},{"key":"45_CR51","doi-asserted-by":"crossref","first-page":"F1105","DOI":"10.1152\/ajprenal.00170.2002","volume":"283","author":"LG Sanchez-Lozada","year":"2002","unstructured":"Sanchez-Lozada LG, Tapia E, Avila-Casado C, et al.: Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 2002, 283:F1105\u20131110. An elegant physiologic study suggesting that hyperuicemia in rats may play a direct pathogenic role as a mechanism that could potentially explain a documented association of gout with hypertension in man.","journal-title":"Am J Physiol Renal Physiol"},{"key":"45_CR52","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.0954-6820.1988.tb19625.x","volume":"224","author":"C Bengtsson","year":"1988","unstructured":"Bengtsson C, Lapidus L, Stendahl C, Waldenstrom J: Hyperuricaemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand 1988, 224:549\u2013555.","journal-title":"Acta Med Scand"},{"key":"45_CR53","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/oxfordjournals.aje.a117479","volume":"141","author":"DS Freedman","year":"1995","unstructured":"Freedman DS, Williamson DF, Gunter EW, Byers T: Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1995, 141:637\u2013644.","journal-title":"Am J Epidemiol"},{"key":"45_CR54","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0895-4356(89)90061-9","volume":"42","author":"W Levine","year":"1989","unstructured":"Levine W, Dyer AR, Shekelle RB, et al.: Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol 1989, 42:257\u2013267.","journal-title":"J Clin Epidemiol"},{"key":"45_CR55","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/pgmj.70.825.486","volume":"70","author":"J Woo","year":"1994","unstructured":"Woo J, Swaminathan R, Cockram C, et al.: Association between serum uric acid and some cardiovascular risk factors in a Chinese population. Postgrad Med J 1994, 70:486\u2013491.","journal-title":"Postgrad Med J"},{"key":"45_CR56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/oxfordjournals.aje.a113972","volume":"121","author":"FN Brand","year":"1985","unstructured":"Brand FN, McGee DL, Kannel WB, et al.: Hyperuricemia as a risk factor of coronary heart disease: the Framingham study. Am J Epidemiol 1985, 121:11\u201318.","journal-title":"Am J Epidemiol"},{"key":"45_CR57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","volume":"131","author":"BF Culleton","year":"1999","unstructured":"Culleton BF, Larson MG, Kannel WB, Levy D: Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999, 131:7\u201313.","journal-title":"Ann Intern Med"},{"key":"45_CR58","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/archinte.1997.00440340060005","volume":"157","author":"AC Gelber","year":"1997","unstructured":"Gelber AC, Klag MJ, Mead LA, et al.: Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins Study. Arch Intern Med 1997, 157:1436\u20131440.","journal-title":"Arch Intern Med"},{"key":"45_CR59","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.CIR.59.5.969","volume":"59","author":"VW Persky","year":"1979","unstructured":"Persky VW, Dyer AR, Idris-Soven E, et al.: Uric acid: a risk factor for coronary heart disease? Circulation 1979, 59:969\u2013977.","journal-title":"Circulation"},{"key":"45_CR60","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1047-2797(97)00204-4","volume":"8","author":"W Rathmann","year":"1998","unstructured":"Rathmann W, Funkhouser E, Dyer AR, Roseman JM: Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Ann Epidemiol 1998, 8:250\u2013261.","journal-title":"Ann Epidemiol"},{"key":"45_CR61","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1523-1755.2004.00484.x","volume":"65","author":"A H\u00f8ieggen","year":"2004","unstructured":"H\u00f8ieggen A, Alderman MH, Kjeldsen SE, et al.: The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004, 65:1041\u20131049. A randomized controlled clinical trial of Losartan demonstrating a modest uricosuric effect and a perceived resultant lower risk for cardiovascular events.","journal-title":"Kidney Int"},{"key":"45_CR62","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.STR.29.3.635","volume":"29","author":"S Lehto","year":"1998","unstructured":"Lehto S, Niskanen L, Ronnemaa T, Laakso M: Serum uric acid is a strong predictor of stroke in patients with non-insulindependent diabetes mellitus. Stroke 1998, 29:635\u2013639.","journal-title":"Stroke"},{"key":"45_CR63","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/01.CIR.0000065637.10517.A0","volume":"107","author":"SD Anker","year":"2003","unstructured":"Anker SD, Doehner W, Rauchhaus M, et al.: Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003, 107:1991\u20131997. This study suggests important associations of hyperuricemia with congestive heart failure.","journal-title":"Circulation"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-996-0045-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-996-0045-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-996-0045-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T13:56:25Z","timestamp":1628949385000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-996-0045-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["45"],"URL":"https:\/\/doi.org\/10.1007\/s11926-996-0045-z","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}